Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 21, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 24, 2025
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-25-000229
Filed / recorded
Oct 24, 2025, 10:11 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
Karthik Kuppusamy
Relationship
Officer
Officer title
SVP, Clinical Solutions
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 21, 2025
Transaction code
A
Shares / units
15
Price per share
$189.076
Acquired / disposed
Acquired (A)
Shares owned after
8,379
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.